ABOUT US

meet us at
Oct. 25th - 27th - 2011
CPHI Frankfurt - Germany
March 12th - 15th - 2012
DCAT New York - USA

LAST NEWS
2011 - Certificate of GMP compliance of a Manufacturer for Human investigational medicinal product

2011 - Certificate of GMP compliance of a Manufacturer for Human medicinal product

MAA CESSION & TRANSFER
Licensing-out opportunity Cetirizine 10 mg/ml, oral solution (NL33352)
NEW MAA CESSION & TRANSFER
Licensing-out opportunity Donepezil 5 mg, ODT (NL37771) and Donepezil 10 mg, ODT (NL37772)
2009 - cGMP Agreement for human use

Galenix Pharma has obtained an updated agreement for cGMP manufacturing, importation and ditribution of human and investigational medicinal products AFSSAPS #M09/168
2008 - cGMP Agreement for veterinary use

Galenix Pharma has obtained an agreement for cGMP manufacturing, importation and distribution of veterinary and investigational medicinal products AFSSA #V1515/08
MAA CESSION & TRANSFER
Licensing-out opportunity Fenofibrate 67 mg, tablet (NL27271) - Fenofibrate 200 mg, tablet (NL27274) and Fenofibrate 160 mg, modified release tablet (NL31360)

newsletter signup
Subscribe Newsletter Please insert your email adress


indentification user
Forgot password Register

Galenix Innovations is an innovative technology platform focusing on drug delivery solutions for life cycle management, new chemical entities using conventional dosage forms or our own patented technologies.

To date, Galenix has patented six innovative Drug Delivery Systems. The aim of DDS is to improve the drug product performances, to enhance the patient's compliance with a smaller tablet size, better taste, slow release, etc. , or to solve an API's problem such as a poor solubility, a poor bioavailablity a high first-pass effect or mode of action that is two short.

Galenix also owns patents on more than twenty drug products compositions and manufacturing processes. Theses patents are licensed out to pharmaceutical companies and protect their products on the market.

Under contract, or for its own needs, Galenix was granted more than 45 Marketing Authorizations Applications (MAA).
Home - About us - Pharmaceutical Services - Clinical Supplies - Drug delivery - Business Opportunities - News - Job offers - Contact
Copyright © 2010 Galenix - Tous droits réservés